The AI-based Medical Image Analysis segmentation by application delineates distinct clinical domains that drive market revenue. Radiology remains the dominant segment, accounting for roughly 40% of total spend, as AI algorithms automate detection of fractures, lesions, and organ volumetrics across CT, MRI, and X‑ray modalities. Oncology follows with an estimated 25% share, where AI‑enhanced image interpretation supports tumor staging, treatment response assessment, and biopsy guidance, thereby reducing diagnostic latency. Cardiology contributes about 15%, leveraging AI for automated echocardiography measurements, coronary artery calcium scoring, and arrhythmia‑related imaging. Neurology captures 12% of the market, focusing on AI‑driven segmentation of brain structures for stroke, multiple sclerosis, and neurodegenerative disease monitoring. Finally, Orthopedics holds an 8% slice, employing AI to quantify bone density, joint space narrowing, and implant positioning. Collectively, these application categories shape the overall market size by reflecting differential adoption rates, reimbursement pathways, and clinical impact across healthcare systems.